In major shift, Pa. to expand hepatitis C treatment for Medicaid patients

Breast cancer: One small drink a day increases risk, study shows
June 9, 2017
Immunotherapy drug opens a new era of precision medicine for cancer
June 12, 2017
Show all

In major shift, Pa. to expand hepatitis C treatment for Medicaid patients

Some states are expanding treatment access for hepatitis C for those on Medicaid.

Under pressure from advocacy organizations that had threatened a lawsuit, the Wolf administration said Tuesday that it would expand Medicaid coverage for treatment of hepatitis C, a major change that many states have put off over fear of spiraling costs.

“Today’s announcement means that thousands of vulnerable Pennsylvanians will soon have easier access to pharmaceuticals that can cure” hepatitis C, Department of Human Services Secretary Ted Dallas said in a statement.

Until now, state policy had been to wait until patients showed signs of liver damage before approving treatment. Allowing earlier treatment was recommended one year ago Wednesday by the department’s Pharmacy and Therapeutics Committee. As time passed without a decision, observers wondered whether the state was trying to determine how to pay for the highly effective but costly new drugs that have made hepatitis C a curable disease.

Read full article: In major shift, Pa. to expand hepatitis C treatment for Medicaid patients

Read Full Article: In major shift, Pa. to expand hepatitis C treatment for Medicaid patients

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.